Drug shows promise for subset of stage III colon cancer patients
A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological ...
Aug 28, 2014
0
1